|
ZSCAN22 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.018000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.832010E-01 |
| Normal-vs-Stage2 |
6.301800E-01 |
| Normal-vs-Stage3 |
2.648600E-01 |
| Normal-vs-Stage4 |
6.376000E-01 |
| Stage1-vs-Stage2 |
7.796400E-01 |
| Stage1-vs-Stage3 |
5.925400E-01 |
| Stage1-vs-Stage4 |
2.775000E-01 |
| Stage2-vs-Stage3 |
5.642800E-01 |
| Stage2-vs-Stage4 |
4.447800E-01 |
| Stage3-vs-Stage4 |
2.955000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.265800E-01 |
| Normal-vs-AfricanAmerican |
5.675800E-01 |
| Normal-vs-Asian |
3.672200E-01 |
| Caucasian-vs-AfricanAmerican |
8.529000E-01 |
| Caucasian-vs-Asian |
8.399400E-01 |
| AfricanAmerican-vs-Asian |
7.630800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.953570E-01 |
| Normal-vs-Female |
6.520000E-01 |
| Male-vs-Female |
1.258180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.602400E-01 |
| Normal-vs-Extreme_Weight |
3.813800E-02 |
| Normal-vs-Obese |
5.076000E-01 |
| Normal-vs-Extreme_Obese |
3.500600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.077800E-01 |
| Normal_Weight-vs-Obese |
1.995440E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.733800E-01 |
| Extreme_Weight-vs-Obese |
2.302100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.169000E-01 |
| Obese-vs-Extreme_Obese |
4.189200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.237200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.652000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.144470E-02 |
| Normal-vs-Age(81-100Yrs) |
6.445700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.528600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.483700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.894000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.614700E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.571600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.641000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.390600E-01 |
| Normal-VS-Type2 PRCC |
8.411600E-04 |
| Normal-VS-KIRP CIMP |
7.776000E-01 |
| Normal-VS-Unclassified PRCC |
6.863400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.606100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.178400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.717600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.678200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.398100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.587000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.396100E-03 |
| Normal-vs-N1 |
7.793200E-01 |
| Normal-vs-N2 |
7.813600E-01 |
| N0-vs-N1 |
7.932500E-02 |
| N0-vs-N2 |
2.238200E-01 |
| N1-vs-N2 |
9.952400E-01 |
|
|
